555 related articles for article (PubMed ID: 15751063)
1. Electroencephalography in the assessment of neuropsychiatric manifestations in antiphospholipid syndrome and systemic lupus erythematosus.
Lampropoulos CE; Koutroumanidis M; Reynolds PP; Manidakis I; Hughes GR; D'Cruz DP
Arthritis Rheum; 2005 Mar; 52(3):841-6. PubMed ID: 15751063
[TBL] [Abstract][Full Text] [Related]
2. Clinical manifestations of the antiphospholipid syndrome in patients with systemic lupus erythematosus associate more strongly with anti-beta 2-glycoprotein-I than with antiphospholipid antibodies.
Cabiedes J; Cabral AR; Alarcón-Segovia D
J Rheumatol; 1995 Oct; 22(10):1899-906. PubMed ID: 8991989
[TBL] [Abstract][Full Text] [Related]
3. Antiphospholipid syndrome nephropathy in patients with systemic lupus erythematosus and antiphospholipid antibodies: prevalence, clinical associations, and long-term outcome.
Tektonidou MG; Sotsiou F; Nakopoulou L; Vlachoyiannopoulos PG; Moutsopoulos HM
Arthritis Rheum; 2004 Aug; 50(8):2569-79. PubMed ID: 15334471
[TBL] [Abstract][Full Text] [Related]
4. Neuropsychiatric manifestations in systemic lupus erythematosus: prevalence and association with antiphospholipid antibodies.
Sanna G; Bertolaccini ML; Cuadrado MJ; Laing H; Khamashta MA; Mathieu A; Hughes GR
J Rheumatol; 2003 May; 30(5):985-92. PubMed ID: 12734893
[TBL] [Abstract][Full Text] [Related]
5. MRI findings in central nervous system systemic lupus erythematosus are associated with immunoserological parameters and hypertension.
Csépány T; Bereczki D; Kollár J; Sikula J; Kiss E; Csiba L
J Neurol; 2003 Nov; 250(11):1348-54. PubMed ID: 14648152
[TBL] [Abstract][Full Text] [Related]
6. Anti-heparin platelet factor 4 antibodies in systemic lupus erythematosus are associated with IgM antiphospholipid antibodies and the antiphospholipid syndrome.
Alpert D; Mandl LA; Erkan D; Yin W; Peerschke EI; Salmon JE
Ann Rheum Dis; 2008 Mar; 67(3):395-401. PubMed ID: 17644539
[TBL] [Abstract][Full Text] [Related]
7. [Antibodies to various phospholipids in SLE patients with primary antiphospholipid syndrome].
Reshetniak TM; Boĭtsekhovskaia B; Alekberova ZS; Kalashnikova LA; Mach ES; Zabek Ia
Klin Med (Mosk); 1999; 77(5):32-7. PubMed ID: 10394784
[TBL] [Abstract][Full Text] [Related]
8. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome.
Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R
J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014
[TBL] [Abstract][Full Text] [Related]
9. Multiple sclerosis, neuropsychiatric lupus and antiphospholipid syndrome: where do we stand?
Ferreira S; D'Cruz DP; Hughes GR
Rheumatology (Oxford); 2005 Apr; 44(4):434-42. PubMed ID: 15644391
[TBL] [Abstract][Full Text] [Related]
10. Cognitive deficits in patients with antiphospholipid syndrome: association with clinical, laboratory, and brain magnetic resonance imaging findings.
Tektonidou MG; Varsou N; Kotoulas G; Antoniou A; Moutsopoulos HM
Arch Intern Med; 2006 Nov; 166(20):2278-84. PubMed ID: 17101948
[TBL] [Abstract][Full Text] [Related]
11. Clinical analysis of cerebrospinal fluid interleukin-6 in neuropsychiatric systemic lupus erythematosus.
Horai Y; Watanabe H; Miyamura T; Takahama S; Hirata A; Nakamura M; Ando H; Minami R; Yamamoto M; Suematsu E
Fukuoka Igaku Zasshi; 2010 Feb; 101(2):34-40. PubMed ID: 20560477
[TBL] [Abstract][Full Text] [Related]
12. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study.
Ainiala H; Dastidar P; Loukkola J; Lehtimäki T; Korpela M; Peltola J; Hietaharju A
Scand J Rheumatol; 2005; 34(5):376-82. PubMed ID: 16234185
[TBL] [Abstract][Full Text] [Related]
13. Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities.
Ainiala H; Hietaharju A; Dastidar P; Loukkola J; Lehtimäki T; Peltola J; Korpela M; Heinonen T; Nikkari ST
Arthritis Rheum; 2004 Mar; 50(3):858-65. PubMed ID: 15022328
[TBL] [Abstract][Full Text] [Related]
14. [Antiphospholipid syndrome and stroke].
Kitagawa Y
Rinsho Shinkeigaku; 2005 Nov; 45(11):852-5. PubMed ID: 16447744
[TBL] [Abstract][Full Text] [Related]
15. The role of antiphospholipid autoantibodies in the cognitive deficits of patients with systemic lupus erythematosus.
Coín MA; Vilar-López R; Peralta-Ramírez I; Hidalgo-Ruzzante N; Callejas-Rubio JL; Ortego-Centeno N; Pérez-García M
Lupus; 2015 Jul; 24(8):875-9. PubMed ID: 25697771
[TBL] [Abstract][Full Text] [Related]
16. Influence of disease duration, continued followup and further antiphospholipid testing on the frequency and classification category of antiphospholipid syndrome in a cohort of patients with systemic lupus erythematosus.
Pérez-Vázquez ME; Villa AR; Drenkard C; Cabiedes J; Alarcón-Segovia D
J Rheumatol; 1993 Mar; 20(3):437-42. PubMed ID: 8478848
[TBL] [Abstract][Full Text] [Related]
17. Antiphospholipid antibodies and migraine: a retrospective study of 428 patients with inflammatory connective tissue diseases.
Tănăsescu R; Nicolau A; Caraiola S; Ticmeanu M; Cojocaru IM; Frăsineanu A; Ionescu R; Hristea A; Ene A; Anghel D; Tănăsescu R; Băicuş C
Rom J Intern Med; 2007; 45(4):355-63. PubMed ID: 18767411
[TBL] [Abstract][Full Text] [Related]
18. [Corticosteroids in the treatment of secondary antiphospholipid syndrome].
Reshetniak TM; Aleksandrova EN; Alekberova ZS; Mach ES; Nasonov EL
Klin Med (Mosk); 2002; 80(6):17-21. PubMed ID: 12138794
[TBL] [Abstract][Full Text] [Related]
19. Valvular heart disease is associated with nonfocal neuropsychiatric systemic lupus erythematosus.
Roldan CA; Gelgand EA; Qualls CR; Sibbitt WL
J Clin Rheumatol; 2006 Feb; 12(1):3-10. PubMed ID: 16484873
[TBL] [Abstract][Full Text] [Related]
20. [Migraine in SLE: role of antiphospholipid antibodies and Raynaud's phenomenon].
Annese V; Tomietto P; Venturini P; D'Agostini S; Ferraccioli G
Reumatismo; 2006; 58(1):50-8. PubMed ID: 16639488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
